ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

ジオスミン

Diosmin

HCID 5281613
反応を作成
印刷
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
520-27-4
標準SMILES
COc1ccc(-c2cc(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3o2)cc1O
InChIKey
GZSOSUNBTXMUFQ-YFAPSIMESA-N
分子式
C28H32O15
平均分子量
608.5 g/mol
単同位体質量
608.17412032

概要

Diosmin is a disaccharide derivative that consists of diosmetin substituted by a 6-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage. It has a role as an antioxidant and an anti-inflammatory agent. It is a monomethoxyflavone, a rutinoside, a dihydroxyflavanone, a glycosyloxyflavone and a disaccharide derivative. It is functionally related to a diosmetin.

名称と識別子

優先名称
Diosmin
IUPAC
5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one
現地名
ジオスミン
英語名
Diosmin
分子式
C28H32O15
分子量
608.55

名称と別名

diosmin520-27-4BarosminVenosmineDiosmineFlebostenToveneVen-DetrexDiovenorBuchu ResinLitosmilflebosmil
名称をさらに表示
バロスミン3',5-ジヒドロキシ-4'-メトキシ-7-(6-O-α-L-ラムノピラノシル-β-D-グルコピラノシルオキシ)フラボンベノサミンヘスペレジン7-[[6-O-(6-デオキシ-α-L-マンノピラノシル)-β-D-グルコピラノシル]オキシ]-2-(3-ヒドロキシ-4-メトキシフェニル)-5-ヒドロキシ-4H-1-ベンゾピラン-4-オン3',5-ジヒドロキシ-4'-メトキシ-7-[[6-O-(α-L-ラムノピラノシル)-β-D-グルコピラノシル]オキシ]フラボン7-[(6-O-α-L-ラムノピラノシル-β-D-グルコピラノシル)オキシ]-3',5-ジヒドロキシ-4'-メトキシフラボンジオスメチン7-ルチノシド7-[6-O-(6-デオキシ-α-L-マンノピラノシル)-β-D-グルコピラノシルオキシ]-3',5-ジヒドロキシ-4'-メトキシフラボンブッフレジン7-[[6-O-(6-デオキシ-α-L-マンノピラノシル)-β-D-グルコピラノシル]オキシ]-5-ヒドロキシ-2-(3-ヒドロキシ-4-メトキシフェニル)-4H-1-ベンゾピラン-4-オンディオスミン3',5,7-トリヒドロキシ-4'-メトキシフラボン7-ルチノシド7-[6-O-(6-デオキシ-α-L-マンノピラノシル)-β-D-グルコピラノシルオキシ]-3′,5-ジヒドロキシ-4′-メトキシフラボン7-[(6-O-α-L-ラムノピラノシル-β-D-グルコピラノシル)オキシ]-3′,5-ジヒドロキシ-4′-メトキシフラボン3′,5-ジヒドロキシ-4′-メトキシ-7-[[6-O-(α-L-ラムノピラノシル)-β-D-グルコピラノシル]オキシ]フラボン3′,5-ジヒドロキシ-4′-メトキシ-7-(6-O-α-L-ラムノピラノシル-β-D-グルコピラノシルオキシ)フラボン

物性

構造計算による物性

XLogP
-0.8
極性表面積
234 Ų
水素結合供与体数
8
水素結合受容体数
15
回転可能結合数
7
重原子数
43
形式電荷
0
複雑度
995

実験および物理化学的性質

Drugs · 2 件

Pharmaceuticals -> Listed in ZINC15

Pharmaceuticals -> Used in Switzerland

LipidsPolyketides [PK] -> Flavonoids [PK12] -> Flavones and Flavonols [PK1211]
CosmeticsAntioxidant
LogP0.14
Boiling Point926.8±65.0
Melting Point277-278
Dissociation Constants6.10±0.40
Collision Cross Section · 2 件

243.33 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

242.5 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

物理化学的性質

融点
277 · 277-278°C
沸点
926.8 · 926.8±65.0 °C(Predicted)
比重(密度)
1.68 · 1.68±0.1 g/cm3(Predicted)

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 3 件

This chemical does not meet GHS hazard criteria for 90.8% (89 of 98) of all reports.

Not Classified

Aggregated GHS information provided per 98 reports by companies from 2 notifications to the ECHA C&L Inventory.

危険有害性情報

Regulatory InformationStatus: Active Update: 13-11-2017 https://echa.europa.eu/registration-dossier/-/registered-dossier/21071
Hazard Classes and CategoriesNot Classified

安全データ

wgk
3
hs_code
29381000
risk_code
36/37/38
hazard_code
Xi
safety_code
26-36-36/37-24/25
ストレージクラス
11 - Combustible Solids

化学と産業

薬理情報

ATC Code · 2 件

C - Cardiovascular system

QC - Cardiovascular system

Protein BindingDiosmin binds to serum albumin.
Pharmacodynamics · 1 件

Diosmin is a venoactive drug supporting circulatory health through various actions on blood vessels; it supports lymphatic drainage and improves microcirculation while increasing venous tone and elasticity. For these reasons, diosmin is frequently taken by individuals with chronic venous disease to support vascular health and has been demonstrated to improve quality of life. In addition to the above effects, diosmin exerts antioxidant activity and scavenges oxygen free radicals, reducing levels of oxidative stress normally detected through biomarkers such as prostaglandins isoprostane precursors. In one clinical study, mean content of TNF alpha, VEGF-C, VEGF-A IL-6, in addition to FGF2 were decreased by after the therapy with diosmin; findings were statistically significant. Additionally, a decrease in edema and mean leg circumference of patients taking diosmin for three months was observed in a clinical study. Diosmin has been demonstrated to enhance the metabolism of glucose in diabetic disorders.

Mechanism of Action · 1 件

Diosmin helps to maintain circulatory system structure and function, particularly vein strength and competence. The molecular mechanism of action of diosmin has not been established. Several resources indicate that diosmin binds to the aryl hydrocarbon receptor, however clinical relevance to vascular function is unknown. One study demonstrates that oral diosmin exerts effects on the in vitro metabolism of noradrenaline by varicose veins, potentially benefitting vascular health.

Biological Half-LifeDiosmin half-life ranges from 26 to 43 hours. One study using a liquid chromatography with tandem mass spectrometry (LC-MS/MS) method after a single 900 mg dose of diosmin demonstrated a half-life of 60.2±85.7 hours in healthy volunteers.
Metabolism/MetabolitesDegradation products of diosmin such as alkyl-phenolic acids confirm a metabolic pattern similar to that of other flavonoids.

関連反応

3 件
反応記録を作成
HRID 61526 の反応式
HRID 61526反応物として
HRID 2222318 の反応式
HRID 2222318反応物として
HRID 2230904 の反応式
HRID 2230904生成物として

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
クリセリオール7-β-ルチノシド
3′-メトキシ-4′,5-ジヒドロキシ-7-(6-O-α-L-ラムノピラノシル-β-D-グルコピラノシルオキシ)フラボン
4′,5-ジヒドロキシ-3′-メトキシ-7-(6-O-α-L-ラムノピラノシル-β-D-グルコピラノシルオキシ)フラボン
DIOSMETIN-7-O-RUTINOSIDE
Hesperedin
DIOSIMIN
SiF6
Rubber powder
Daflon
Diosmin CRS
Dioven
iosmin
DiosminumFlebavenaDiosmetin 7-O-rutinosideDiosvenFlebavenHemervenInsuvenVarinon

データベース識別子

CAS
520-27-4
PubChem CID
5281613
DTXSID
DTXSID4045892
ChEMBL
CHEMBL231884
ChEBI
CHEBI:4631
UNII
7QM776WJ5N
EC Number
208-289-7
Nikkaji
J6.600A
蒸気圧
0 Pa · 0Pa at 20℃
貯蔵温度
2 · Sealed in dry,2-8°C
溶解性
水にほとんど溶けず、ジメチルスルホキシドに溶け、アルコールにほとんど溶けない。アルカリ金属水酸化物の希薄溶液に溶けます。
外見
Solid
酸解離定数(Pka)
6.1 · 6.10±0.40(Predicted)
色
ペールベージュからブラウン
水溶解度
DMSO (50 mg/ml)、水 (122 mg/ml、25°C)、エタノール (<1 mg/ml、25°C) に可溶。
Merck
14 · 14,3297
主な用途
食品および飲料
化粧品成分の機能
抗酸化物質
InChIKey
GZSOSUNBTXMUFQ-YFAPSIMESA-N
SMILES
COc1ccc(cc1O)C2=CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2
LogP
0.14 at · 0.14 at 20℃
CAS データベース
520 · 520-27-4(CAS DataBase Reference)
化学的性質 · 1 件

化学的特性Diosmin is a natural flavonoid mainly present in the peel of some citrus fruits, such as oranges and lemons. Flavonoids are anti-inflammatory plant compounds that protect your body from free radicals and other unstable molecules. The most prevalent uses for Diosmin include hemorrhoids and leg sores caused by poor blood flow. Diosmin was first found in 1925 in the wort plant and has since been used as a natural treatment for hemorrhoids, varicose veins, venous insufficiency, leg ulcers, and other circulatory issues.

Absorption, Distribution and Excretion · 3 件

Diosmin is rapidly absorbed in the gastrointestinal tract. After a 900 mg single oral dose in a study using liquid chromatography with tandem mass spectrometry (LC-MS/MS) method, Cmax was 4.2±3.8 ng·mL-1, Tmax was 18.7±9.9 hours, and AUC0~96 was 185.4±166.2 ng·mL-1 in healthy volunteers. Another pharmacokinetic study of 5 adults revealed a Cmax of 417±94.1 ng/dL.

Pharmacokinetic data show absence of urinary elimination for diosmin and its aglycone diosmetin. Minor metabolites are found to be eliminated in the urine as glucuronic acid conjugates.

A pharmacokinetic study of 5 adults revealed a volume of distribution of 62.1±7.9 L.

用途と製造

UsesUse (kg) in France (2004): 373544
Use ClassificationCosmetics -> Antioxidant
応用分野 · 4 件

用途ジオスミン(英: Diosmin)はジオスメチンの7位にルチノースが結合したフラボノイド配糖体。柑橘類の果実に含まれている。。ジオスミンは血管保護作用があるとされ、慢性静脈不全、痔、リンパ水腫、静脈瘤に使用される。

説明Diosmin was separated from the root of Scrophularia nodosa L. in 1925. The root of Scrophularia nodosa L. has the function of nourishing, reducing fever, relieving internal heat, and detoxicating. It was firstly recorded in the Shen Nong’s Classic of Materia Medica, as a class of middle-grade drug and is currently recorded in the Ch.P 2015, Volume I. The natural resource was abundant in China, mainly provided from Zhejiang, Sichuan, Hubei, Anhui, and Jiangsu provinces. In the clinical practice, Scrophularia nodosa L. was employed to eliminate pathogenic heat from the blood. In the clinical indication, diosmin was mainly applied to treat fever, polydipsia, maculitis, gingivitis, amygdalitis, laryngopharyngitis, acute lymphadenitis, etc. It also has the biological function of antiplatelet aggregation and antitumor. The chemical components include iridoids, phenylpropanoid glycoside, flavonoids, and fatty acids.

来歴Diosmin was firstly introduced as a medicine in 1969. It was launched in France in 1987 with the product name “Alvenor.” As the protecting agent for blood vessel and therapeutic agent for chronic venous disease, diosmin has been used for over 30years in EuropeDiosmin is a typical flavonoid. It could be prepared from natural resources or semisynthesized from the natural product hesperidin by dehydrogenation reaction.

使用Diosmin is an agonist of the aryl hydrocarbon receptor (AhR) and exhibits anti-proliferative and anti-inflammatory. It is used in the treatment of venous disease, i.e., chronic venous insufficiency (CVI) and hemorrhoidal disease (HD). Diosmin also reduces capillary hyperpermeability and expression of endothelial adhesion molecules (ICAM1, VCAM1). It effectively inhibits the P-glycoprotein (Pgp)-mediated efflux in cells.

上流・下流製品情報

上流原料

水酸化ナトリウム酢酸ヘスペリジン無水酢酸
補足説明 · 1 件

定義ChEBI: Diosmin is a disaccharide derivative that consists of diosmetin substituted by a 6-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage. It has a role as an antioxidant and an anti-inflammatory agent. It is a glycosyloxyflavone, a rutinoside, a disaccharide derivative, a monomethoxyflavone and a dihydroxyflavanone. It derives from a diosmetin.